Cargando…
D1 receptor‐mediated endogenous tPA upregulation contributes to blood‐brain barrier injury after acute ischaemic stroke
Blood‐brain barrier (BBB) integrity injury within the thrombolytic time window is becoming a critical target to reduce haemorrhage transformation (HT). We have previously reported that BBB damage was initially damaged in non‐infarcted striatum after acute ischaemia stroke. However, the underlying me...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417722/ https://www.ncbi.nlm.nih.gov/pubmed/32627929 http://dx.doi.org/10.1111/jcmm.15570 |
_version_ | 1783569556794507264 |
---|---|
author | Wang, Yan Wang, Xiaona Zhang, Xinyu Chen, Shuang Sun, Yanyun Liu, Wenlan Jin, Xinchun Zheng, Guoqing |
author_facet | Wang, Yan Wang, Xiaona Zhang, Xinyu Chen, Shuang Sun, Yanyun Liu, Wenlan Jin, Xinchun Zheng, Guoqing |
author_sort | Wang, Yan |
collection | PubMed |
description | Blood‐brain barrier (BBB) integrity injury within the thrombolytic time window is becoming a critical target to reduce haemorrhage transformation (HT). We have previously reported that BBB damage was initially damaged in non‐infarcted striatum after acute ischaemia stroke. However, the underlying mechanism is not clear. Since acute ischaemic stroke could induce a significant increase of dopamine release in striatum, in current study, our aim is to investigate the role of dopamine receptor signal pathway in BBB integrity injury after acute ischaemia using rat middle cerebral artery occlusion model. Our data showed that 2‐h ischaemia induced a significant increase of endogenous tissue plasminogen activator (tPA) in BBB injury area and intra‐striatum infusion of tPA inhibitor neuroserpin, significantly alleviated 2‐h ischaemia‐induced BBB injury. In addition, intra‐striatum infusion of D1 receptor antagonist SCH23390 significantly decreased ischaemia‐induced upregulation of endogenous tPA, accompanied by decrease of BBB injury and occludin degradation. More important, inhibition of hypoxia‐inducible factor‐1 alpha with inhibitor YC‐1 significantly decreased 2‐h ischaemia‐induced endogenous tPA upregulation and BBB injury. Taken together, our data demonstrate that acute ischaemia disrupted BBB through activation of endogenous tPA via HIF‐1α upregulation, thus representing a new therapeutic target for protecting BBB after acute ischaemic stroke. |
format | Online Article Text |
id | pubmed-7417722 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74177222020-08-11 D1 receptor‐mediated endogenous tPA upregulation contributes to blood‐brain barrier injury after acute ischaemic stroke Wang, Yan Wang, Xiaona Zhang, Xinyu Chen, Shuang Sun, Yanyun Liu, Wenlan Jin, Xinchun Zheng, Guoqing J Cell Mol Med Original Articles Blood‐brain barrier (BBB) integrity injury within the thrombolytic time window is becoming a critical target to reduce haemorrhage transformation (HT). We have previously reported that BBB damage was initially damaged in non‐infarcted striatum after acute ischaemia stroke. However, the underlying mechanism is not clear. Since acute ischaemic stroke could induce a significant increase of dopamine release in striatum, in current study, our aim is to investigate the role of dopamine receptor signal pathway in BBB integrity injury after acute ischaemia using rat middle cerebral artery occlusion model. Our data showed that 2‐h ischaemia induced a significant increase of endogenous tissue plasminogen activator (tPA) in BBB injury area and intra‐striatum infusion of tPA inhibitor neuroserpin, significantly alleviated 2‐h ischaemia‐induced BBB injury. In addition, intra‐striatum infusion of D1 receptor antagonist SCH23390 significantly decreased ischaemia‐induced upregulation of endogenous tPA, accompanied by decrease of BBB injury and occludin degradation. More important, inhibition of hypoxia‐inducible factor‐1 alpha with inhibitor YC‐1 significantly decreased 2‐h ischaemia‐induced endogenous tPA upregulation and BBB injury. Taken together, our data demonstrate that acute ischaemia disrupted BBB through activation of endogenous tPA via HIF‐1α upregulation, thus representing a new therapeutic target for protecting BBB after acute ischaemic stroke. John Wiley and Sons Inc. 2020-07-06 2020-08 /pmc/articles/PMC7417722/ /pubmed/32627929 http://dx.doi.org/10.1111/jcmm.15570 Text en © 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Wang, Yan Wang, Xiaona Zhang, Xinyu Chen, Shuang Sun, Yanyun Liu, Wenlan Jin, Xinchun Zheng, Guoqing D1 receptor‐mediated endogenous tPA upregulation contributes to blood‐brain barrier injury after acute ischaemic stroke |
title | D1 receptor‐mediated endogenous tPA upregulation contributes to blood‐brain barrier injury after acute ischaemic stroke |
title_full | D1 receptor‐mediated endogenous tPA upregulation contributes to blood‐brain barrier injury after acute ischaemic stroke |
title_fullStr | D1 receptor‐mediated endogenous tPA upregulation contributes to blood‐brain barrier injury after acute ischaemic stroke |
title_full_unstemmed | D1 receptor‐mediated endogenous tPA upregulation contributes to blood‐brain barrier injury after acute ischaemic stroke |
title_short | D1 receptor‐mediated endogenous tPA upregulation contributes to blood‐brain barrier injury after acute ischaemic stroke |
title_sort | d1 receptor‐mediated endogenous tpa upregulation contributes to blood‐brain barrier injury after acute ischaemic stroke |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417722/ https://www.ncbi.nlm.nih.gov/pubmed/32627929 http://dx.doi.org/10.1111/jcmm.15570 |
work_keys_str_mv | AT wangyan d1receptormediatedendogenoustpaupregulationcontributestobloodbrainbarrierinjuryafteracuteischaemicstroke AT wangxiaona d1receptormediatedendogenoustpaupregulationcontributestobloodbrainbarrierinjuryafteracuteischaemicstroke AT zhangxinyu d1receptormediatedendogenoustpaupregulationcontributestobloodbrainbarrierinjuryafteracuteischaemicstroke AT chenshuang d1receptormediatedendogenoustpaupregulationcontributestobloodbrainbarrierinjuryafteracuteischaemicstroke AT sunyanyun d1receptormediatedendogenoustpaupregulationcontributestobloodbrainbarrierinjuryafteracuteischaemicstroke AT liuwenlan d1receptormediatedendogenoustpaupregulationcontributestobloodbrainbarrierinjuryafteracuteischaemicstroke AT jinxinchun d1receptormediatedendogenoustpaupregulationcontributestobloodbrainbarrierinjuryafteracuteischaemicstroke AT zhengguoqing d1receptormediatedendogenoustpaupregulationcontributestobloodbrainbarrierinjuryafteracuteischaemicstroke |